Clinical Trial Update: Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated intra-arterial cisplatin plus rh-endostatin with systemic chemotherapy in osteosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• CISPLATIN (cisplatin)
• rh-endostatin (recombinant human endostatin)

Snippet

Sponsor: Shanghai 6th People's Hospital | Conditions: Osteosarcoma, Bone Cancer | Phase 1, Phase 2 | Status: COMPLETED